Document is current
Any future updates will be listed below
-
Authors
Kumluang, Suthasinee
Ingsrisawang, Lily https://orcid.org/0000-0001-6177-1587
Sangroongruangsri, Sermsiri
Chaikledkaew, Usa
Ratanapakorn, Tanapat
Ruamviboonsuk, Paisan
Taweebanjongsin, Wongsiri
Choovuthayakorn, Janejit
Thoongsuwan, Somanus
Hanutsaha, Prut
Kulvichit, Kittisak
Ratanapojnard, Thitiporn
Wongsawad, Warapat
Leelahavarong, Pattara
Teerawattananon, Yot
-
Funding
Funding for this research was provided by:
Health Systems Research Institute (HSRI. 59-005)
Thailand Research Fund (RTA 5980011)
The Royal Golden Jubilee Ph.D. Program (PHD/0180/2554)
The Royal Golden Jubilee Ph.D. Program (PHD/0180/2554)
- License Information
-
More Information
Article History
Received: 27 March 2018
Accepted: 6 March 2019
First Online: 29 March 2019
Ethics approval and consent to participate
: This research was approved by the Institute for the Development of Human Research Protections, Ministry of Public Health, Thailand (IHRP.32/2012), the Thai Clinical Trials Registry (TCTR20141002001), and the institutional review board of each hospital. All patients were enrolled into the study after providing written informed consent.
: Not applicable.
: Prut Hanutsaha has received an honorarium and travel support from Novartis to attend a scientific meeting. Wongsiri Taweebanjongsin has received an honorarium from Novartis, a travel support to meeting from TRB Chemedica, and payment for lectures from Novartis and Bayer. Other authors declare that they have no competing interests which are directly relevant to the content of this study.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
